Cor Vasa 2013, 55(2):e201-e206 | DOI: 10.1016/j.crvasa.2013.02.006

Protocols of antithrombotic therapy in a University Cardiocenter

Petr Widimský, Zuzana Moťovská*, Tomáš Vaněk, Hana Línková, Viktor Kočka
Kardiocentrum 3. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha, Česká republika

This article presents local protocols for antithrombotic therapy used in a tertiary care institution - the cardiocenter of a university hospital. The protocols were discussed in detail among the whole team of physicians of the cardiocenter. This article addresses cardiac conditions requiring hospitalization whenever antithrombo-tic therapy is indicated. These protocols do not include antithrombotic therapy in other medicinal disciplines (e.g., orthopedics, surgery). These protocols are mostly based on the current guidelines of the European Society of Cardiology (ESC). The partial differences between the ESC guidelines and this text are usually based on the results of the latest clinical trials, which have not yet been included in the ESC guidelines.

Keywords: Acute coronary syndrome; Antiaggregation drugs; Anticoagulant drugs; Antithrombotic therapy; Atrial fibrillation; Coronary artery bypass graft surgery; Percutaneous coronary intervention; Thromboembolic disease

Received: January 9, 2013; Accepted: February 19, 2013; Published: April 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský P, Moťovská Z, Vaněk T, Línková H, Kočka V. Protocols of antithrombotic therapy in a University Cardiocenter. Cor Vasa. 2013;55(2):e201-206. doi: 10.1016/j.crvasa.2013.02.006.
Download citation

References

  1. P.G. Steg, S.K. James, D. Atar, et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, European Heart Journal 33 (2012) 2569-2619. Go to original source... Go to PubMed...
  2. C.W. Hamm, J.P. Bassand, S. Agewall, et al., ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, European Heart Journal 32 (2011) 2999-3054. Go to original source... Go to PubMed...
  3. A.J. Camm, P. Kirchhof, G.Y.H. Lipp, et al., Guidelines for the management of atrial fibrillation, European Heart Journal 31 (2010) 2369-2429. Go to original source... Go to PubMed...
  4. W. DeWilde, T. Oirbans, F. Verheugt, et al., WOEST: first randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI). http://www.escardio.org/congresses/esc-2012/congress-reports/Pages/708-2-WOEST.aspx
  5. A. Vahanian, O. Alfieri, F. Andreotti, et al., Guidelines on the management of valvular heart disease (version 2012), European Heart Journal 33 (2012) 2451-2496. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.